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Introduction
Psoriasis is a common chronic inflammatory skin disorder
affecting ~2% of the population worldwide. Both the adap-
tive and innate immune systems are important in driving
the inflammation in genetically susceptible individuals.
HLA-Cw6 located within the PSORS1 region on chromo-
some 6 is the most important psoriasis genetic marker.
Correlations of HLA-C expression with different disease
incidence and progression are described in the context of
HLA-C’s interaction with killer-like immunoglobulin
receptors (KIR) expressed on innate immune effector cells;
natural killer (NK) and natural killer T (NKT) cells.
Aim
We aimed to study the expression of KIR2DL1, the nat-
ural receptor for HLA-Cw6, in blood and skin of psoria-
sis patients and normal controls.
Patients and methods
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from blood samples of psoriasis patients (n = 46)
and normal controls (n = 10). The expression of skin
homing markers and the cytokine production profile of
peripheral KIR2DL1+ lymphocytes were further studied
by flow cytometry analysis. Demonstration of KIR2DL1
cells in skin was performed with immunofluorescence
(IF) staining and confocal imaging on frozen skin sec-
tions (n = 3) and epidermal sheets (n = 3).
Results
The majority of blood derived KIR2DL1+ lymphocytes
are NK cells expressing CD56 with a small percentage of
NKT cells expressing both CD56 and CD3. Peripheral
KIR2DL1+ lymphocytes express a range of skin homing
markers including CLA, CCR4, CCR6 and CCR10,
indicating their capacity to migrate from the periphery to
skin. Furthermore, these cells are capable of producing
different psoriasis relevant cytokines such as TNFa and
IFNg. IF staining demonstrated CD56+/CD3+ KIR2DL1+
cells in epidermis and dermal-epidermal junctions in
both normal and psoriasis skin.
Conclusion
This is the first in situ demonstration of KIR2DL1+ cells
in psoriasis skin. Their interaction with HLA-Cw6
expressing cells might affect the cytokine milieu in psor-
iasis and constitute a novel innate immune pathway
important in psoriasis pathogenesis.
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